Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain: an Observational Prospective Study


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT04123652

Organisation Name: Allevio Pain Management Clinic

Overal Status: Recruiting

Start Date: December 5, 2018

Last Update: October 14, 2019

Lead Sponsor: Allevio Pain Management Clinic

Brief Summary: As lidocaine and ketamine provide analgesia by acting on different molecular pathways, administering them together may produce synergistic effects, which can allow for using a lower dose of each medication and thereby reducing the corresponding side effects. To the investigator's knowledge, despite the common practice of multimodal analgesia, lidocaine-ketamine infusions have never been studied prospectively in an out of hospital setting to treat neuropathic pain. The aim of the present study is to evaluate the effectiveness of the current routine practice of lidocaine-ketamine infusions conducted at Allevio Pain Management Clinic, a large outpatient community based chronic pain management facility. Lidocaine-ketamine infusions are prescribed to patients that have pain that is considered to be neuropathic for which standard anti-neuropathic medications have been ineffective or poorly tolerated by patients. A prospective longitudinal study.

Conditions:
  • Chronic Neuropathic Pain and Fibromyalgia


Total execution time in seconds: 0.16009187698364